Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $2.474B (100.0% shares, 0.0% debt)

Holdings (36)

— ABIOMED INC 12.9%
Value $319M Shares 708,917 Share Price $449.75 Est. Cost/Share $32.04 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 10.0%
Value $247M Shares 2,549,431 Share Price $96.97 * Est. Cost/Share $79.79 Unrealized @ Report Date +25.1%
UTHR UNITED THERAPEUTICS CORP DEL 8.4%
Value $208M Shares 1,625,234 Share Price $127.88 * Est. Cost/Share $88.73 Unrealized @ Report Date +39.4%
STAA STAAR SURGICAL CO 6.8%
Value $169M Shares 3,521,565 Share Price $48.00 * Est. Cost/Share $8.00 Unrealized @ Report Date +411.6%
— ALEXION PHARMACEUTICALS INC 6.7%
Value $167M Shares 1,200,201 Share Price $139.01 Est. Cost/Share $121.26 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 6.2%
Value $153M Shares 5,221,026 Share Price $29.37 Est. Cost/Share $51.30 Unrealized @ Report Date —
INSM INSMED INC 6.0%
Value $149M Shares 7,357,283 Share Price $20.22 * Est. Cost/Share $16.87 Unrealized @ Report Date +34.1%
— SAGE THERAPEUTICS INC 4.8%
Value $119M Shares 840,372 Share Price $141.25 Est. Cost/Share $48.02 Unrealized @ Report Date —
— IMMUNOMEDICS INC 4.2%
Value $104M Shares 5,013,764 Share Price $20.83 Est. Cost/Share $11.93 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 3.9%
Value $95.37M Shares 4,155,670 Share Price $22.95 * Est. Cost/Share $8.70 Unrealized @ Report Date +134.6%
— WRIGHT MED GROUP N V 3.2%
Value $80.03M Shares 2,757,587 Share Price $29.02 Est. Cost/Share $23.42 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 3.2%
Value $79.42M Shares 4,663,324 Share Price $17.03 Est. Cost/Share $18.85 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 3.1%
Value $76.97M Shares 6,366,147 Share Price $12.09 * Est. Cost/Share $6.67 Unrealized @ Report Date +109.5%
— EPIZYME INC 3.0%
Value $73.2M Shares 6,906,158 Share Price $10.60 Est. Cost/Share $15.12 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 2.7%
Value $67.61M Shares 3,380,506 Share Price $20.00 Est. Cost/Share $29.26 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 2.3%
Value $57.83M Shares 147,807 Share Price $391.22 * Est. Cost/Share $98.66 Unrealized @ Report Date +274.0%
— MOMENTA PHARMACEUTICALS INC 1.9%
Value $48.22M Shares 1,833,532 Share Price $26.30 Est. Cost/Share $14.12 Unrealized @ Report Date —
— CELGENE CORP 1.6%
Value $38.41M Shares 429,267 Share Price $89.49 Est. Cost/Share $95.03 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 1.5%
Value $37.69M Shares 1,381,759 Share Price $27.28 Est. Cost/Share $23.79 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 1.4%
Value $34.96M Shares 1,684,180 Share Price $20.76 * Est. Cost/Share $29.54 Unrealized @ Report Date -46.7%
— SHIRE PLC 1.4%
Value $34.94M Shares 192,738 Share Price $181.27 Est. Cost/Share $197.13 Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 1.2%
Value $30.85M Shares 1,853,101 Share Price $16.65 Est. Cost/Share $11.48 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 1.0%
Value $24.73M Shares 313,320 Share Price $78.92 * Est. Cost/Share $13.61 Unrealized @ Report Date +379.0%
PRTA PROTHENA CORP PLC 0.6%
Value $14.43M Shares 1,103,325 Share Price $13.08 * Est. Cost/Share $32.98 Unrealized @ Report Date -56.2%
GILD GILEAD SCIENCES INC 0.5%
Value $13.58M Shares 175,900 Share Price $77.21 * Est. Cost/Share $62.02 Unrealized @ Report Date -8.4%
— RIGEL PHARMACEUTICALS INC 0.5%
Value $12.73M Shares 3,966,087 Share Price $3.21 Est. Cost/Share $3.40 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.3%
Value $7.644M Shares 500,913 Share Price $15.26 Est. Cost/Share $5.39 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $2.954M Shares 3,013,793 Share Price $0.98 Est. Cost/Share $4.88 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $2.325M Shares 1,162,473 Share Price $2.00 Est. Cost/Share $4.37 Unrealized @ Report Date —
— ZOGENIX INC 0.1%
Value $1.463M Shares 29,500 Share Price $49.59 Est. Cost/Share $13.36 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.0%
Value $1.218M Shares 123,686 Share Price $9.85 * Est. Cost/Share $6.71 Unrealized @ Report Date +19.5%
— TREVENA INC 0.0%
Value $724K Shares 341,300 Share Price $2.12 Est. Cost/Share $2.30 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $689K Shares 247,000 Share Price $2.79 Est. Cost/Share $2.60 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $686K Shares 77,044 Share Price $8.90 Est. Cost/Share $8.90 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $200K Shares 50,689 Share Price $3.95 Est. Cost/Share $15.80 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $165K Shares 302,922 Share Price $0.54 Est. Cost/Share $11.00 Unrealized @ Report Date —